Código QR (código de barras bidimensional)

Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective study

ObjectivesTo compare the safety and efficacy of lenvatinib (LEN) combined with camrelizumab plus transcatheter arterial chemoembolization (TACE-LEN-C) and TACE combined with LEN (TACE-LEN) in patients with unresectable hepatocellular carcinoma (uHCC).MethodsEighty-three patients with uHCC treated wi...

ver descrição completa

Na minha lista:
Principais autores: Bo Sun, Lijie Zhang, Tao Sun, Yanqiao Ren, Yanyan Cao, Weihua Zhang, Licheng Zhu, Yusheng Guo, Yuxi Gui, Fengyong Liu, Lei Chen, Fu Xiong, Chuansheng Zheng
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2022-09-01
coleção:Frontiers in Oncology
Assuntos:
lenvatinib
transcatheter arterial chemoembolization
camrelizumab
hepatocellular carcinoma
efficacy
safety
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fonc.2022.982948/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados